Connect with us

Strattera (atomoxetine)


Atomoxetine (or STRATTERA®) is mainly prescribed to treat attention deficit hyperactivity disorder.

Status: ACTIVE

Class: Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Norepinephrine Reuptake Inhibitor (NRI)

FDA Approval: 2002

Dosage Forms: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg

Biological Half-life: 4.5-19 hours

Side Effects: Dizziness, blurred vision, dry mouth, nausea, insomnia, fatigue, abnormal dreams, sweating, low libido, appetite changes, hot flashes, cough, hypertension, tachycardia, hyperhidrosis, mood swings, sexual dysfunction

Routes of Administration: Oral

Pregnancy Category: C (US)

  www.strattera.com

Like Us

Advertisement
Advertisement